Home › NDC Lookup › RxCUI directory › RxCUI 905158

Sirolimus 0.5 MG Oral Tablet — RxCUI 905158

RxNorm drug concept · Semantic clinical drug
RxCUI 905158 Semantic clinical drug · SCD ● Current RxNorm concept 22 FDA products 45 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI905158
Official nameSirolimus 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped22
Package NDCs mapped45
Reported Medicaid activity (SDUD)22,349 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sirolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sirolimus comes in a few different forms, and each one has its own approved use. The oral tablets and liquid are mainly used to prevent kidney transplant rejection and to treat a r...
  • What exactly is sirolimus being used for — I've seen it listed for so many different things?
  • Yes, it matters — but not in the way you might think. You don't have to eat with it, but you do need to be consistent. Food, especially a high-fat meal, can increase how much sirol...
  • Does it matter if I take my oral sirolimus with food or without?
📖 Read our full Sirolimus guide →

🕸️ Concept Web — How Sirolimus 0.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sirolimus 0.5 MG Oral Tablet RxCUI 905158

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sirolimus 35302
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rapamune 258355
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sirolimus Oral Tablet 378277
    • Sirolimus Oral Product 1158758
    • Sirolimus Pill 1158759
    • Sirolimus Oral Tablet [Rapamune] 368672
    • Rapamune Oral Product 1177702
    • Rapamune Pill 1177703
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sirolimus 0.5 MG 905157
    • Sirolimus 0.5 MG Oral Tablet [Rapamune] 905160
    • Sirolimus 0.5 MG [Rapamune] 905159

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sirolimus 0.5 MG SCDC · 905157
  • Sirolimus Oral Tablet SCDF · 378277
  • Sirolimus Oral Product SCDG · 1158758
  • Sirolimus Pill SCDG · 1158759

Brand-Name Concepts

  • Sirolimus 0.5 MG Oral Tablet [Rapamune] SBD · 905160
  • Sirolimus 0.5 MG [Rapamune] SBDC · 905159
  • Sirolimus Oral Tablet [Rapamune] SBDF · 368672
  • Rapamune Oral Product SBDG · 1177702
  • Rapamune Pill SBDG · 1177703
  • Rapamune BN · 258355

📦 FDA Products & Package NDCs

22 products · 45 package NDCs
45 package NDCs map to RxCUI 905158 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
16714-0187-01 100 TABLET, FILM COATED in 1 BOTTLE (16714-187-01) sirolimus NORTHSTAR RX LLC 2021-10-18
16714-0188-01 100 TABLET, FILM COATED in 1 BOTTLE (16714-188-01) sirolimus NORTHSTAR RX LLC 2021-10-18
16714-0189-01 100 TABLET, FILM COATED in 1 BOTTLE (16714-189-01) sirolimus NORTHSTAR RX LLC 2021-10-18
59762-1001-01 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1001-1) Sirolimus Mylan Pharmaceuticals Inc. 2014-01-07
59762-1002-01 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1002-1) Sirolimus Mylan Pharmaceuticals Inc. 2014-10-27
59762-1003-01 100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1) Sirolimus Mylan Pharmaceuticals Inc. 2014-10-27
60687-0902-21 30 BLISTER PACK in 1 CARTON (60687-902-21) / 1 TABLET, FILM... sirolimus American Health Packaging 2026-06-02
65841-0771-01 100 TABLET, FILM COATED in 1 BOTTLE (65841-771-01) sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0771-05 500 TABLET, FILM COATED in 1 BOTTLE (65841-771-05) sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0771-06 30 TABLET, FILM COATED in 1 BOTTLE (65841-771-06) sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0771-10 1000 TABLET, FILM COATED in 1 BOTTLE (65841-771-10) sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0771-16 90 TABLET, FILM COATED in 1 BOTTLE (65841-771-16) sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0771-77 10 BLISTER PACK in 1 CARTON (65841-771-77) / 10 TABLET, FIL... sirolimus Zydus Lifesciences Limited 2014-01-15
65841-0772-01 100 TABLET, FILM COATED in 1 BOTTLE (65841-772-01) sirolimus Zydus Lifesciences Limited 2023-02-16
65841-0772-77 10 BLISTER PACK in 1 CARTON (65841-772-77) / 10 TABLET, FIL... sirolimus Zydus Lifesciences Limited 2023-02-16
65841-0773-01 100 TABLET, FILM COATED in 1 BOTTLE (65841-773-01) sirolimus Zydus Lifesciences Limited 2023-02-16
65841-0773-77 10 BLISTER PACK in 1 CARTON (65841-773-77) / 10 TABLET, FIL... sirolimus Zydus Lifesciences Limited 2023-02-16
67877-0746-01 100 TABLET, FILM COATED in 1 BOTTLE (67877-746-01) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0746-05 500 TABLET, FILM COATED in 1 BOTTLE (67877-746-05) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0746-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-746-30) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0746-38 100 BLISTER PACK in 1 CARTON (67877-746-38) / 10 TABLET, FI... Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0747-01 100 TABLET, FILM COATED in 1 BOTTLE (67877-747-01) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0747-05 500 TABLET, FILM COATED in 1 BOTTLE (67877-747-05) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0747-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-747-30) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0747-38 100 BLISTER PACK in 1 CARTON (67877-747-38) / 10 TABLET, FI... Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0748-01 100 TABLET, FILM COATED in 1 BOTTLE (67877-748-01) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0748-05 500 TABLET, FILM COATED in 1 BOTTLE (67877-748-05) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0748-30 30 TABLET, FILM COATED in 1 BOTTLE (67877-748-30) Sirolimus Ascend Laboratories, LLC 2021-03-13
67877-0748-38 100 BLISTER PACK in 1 CARTON (67877-748-38) / 10 TABLET, FI... Sirolimus Ascend Laboratories, LLC 2021-03-13
68382-0351-01 100 TABLET, FILM COATED in 1 BOTTLE (68382-351-01) sirolimus Zydus Pharmaceuticals USA Inc. 2023-02-16
68382-0351-77 10 BLISTER PACK in 1 CARTON (68382-351-77) / 10 TABLET, FIL... sirolimus Zydus Pharmaceuticals USA Inc. 2023-02-16
68382-0352-01 100 TABLET, FILM COATED in 1 BOTTLE (68382-352-01) sirolimus Zydus Pharmaceuticals USA Inc. 2023-02-16
68382-0352-77 10 BLISTER PACK in 1 CARTON (68382-352-77) / 10 TABLET, FIL... sirolimus Zydus Pharmaceuticals USA Inc. 2023-02-16
68382-0520-01 100 TABLET, FILM COATED in 1 BOTTLE (68382-520-01) sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68382-0520-05 500 TABLET, FILM COATED in 1 BOTTLE (68382-520-05) sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68382-0520-06 30 TABLET, FILM COATED in 1 BOTTLE (68382-520-06) sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68382-0520-10 1000 TABLET, FILM COATED in 1 BOTTLE (68382-520-10) sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68382-0520-16 90 TABLET, FILM COATED in 1 BOTTLE (68382-520-16) sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68382-0520-77 10 BLISTER PACK in 1 CARTON (68382-520-77) / 10 TABLET, FIL... sirolimus Zydus Pharmaceuticals USA Inc. 2014-01-15
68462-0682-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-682-01) sirolimus Glenmark Pharmaceuticals Inc., USA 2020-10-16
68462-0683-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-683-01) sirolimus Glenmark Pharmaceuticals Inc., USA 2020-10-16
68462-0684-01 100 TABLET, FILM COATED in 1 BOTTLE (68462-684-01) sirolimus Glenmark Pharmaceuticals Inc., USA 2020-10-16
70518-3546-00 100 POUCH in 1 BOX (70518-3546-0) / 1 TABLET in 1 POUCH (70... Sirolimus REMEDYREPACK INC. 2022-09-30
70518-4376-00 100 POUCH in 1 BOX (70518-4376-0) / 1 TABLET, FILM COATED i... sirolimus REMEDYREPACK INC. 2025-06-28
70518-4449-00 100 POUCH in 1 BOX (70518-4449-0) / 1 TABLET, FILM COATED i... sirolimus REMEDYREPACK INC. 2025-08-19
Observed labelers: Ascend Laboratories, LLC (12) · Zydus Lifesciences Limited (10) · Zydus Pharmaceuticals USA Inc. (10) · Glenmark Pharmaceuticals Inc., USA (3) · Mylan Pharmaceuticals Inc. (3) · NORTHSTAR RX LLC (3) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7520 Sirolimus, oral 12 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.